Tissera
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1065 Ave of Americas, New York City, New...Website
www.tissera.comRevenue
<$5 MillionIndustry
About Tissera
Tissera Org Chart
Is Tissera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Tissera launches new products
Funding: Get notified immidiatlly once Tissera has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Tissera, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Tissera
Earning: See what the market has to say on Tissera recently announced quarterly report
Check out if Tissera is spiking on competitors!
Check if Tissera has recently received funding, and reach out quickly before it becomes old news!
Click to see if Tissera had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Tissera
Find 3 more new buyers
Compare Similar Companies to Tissera
Compare insights from companies similar to Tissera, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Tissera is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Tissera is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Tissera.
Tissera Tech Stack
A closer look at the technologies used by Tissera
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Tissera
Tissera is a biotechnology company dedicated to the development of novel tissue precursor regeneration technologies for treating gene deficiencies and diseases in which organ transplantation is necessary, while minimizing the dosage of immunosuppressive drugs. Tissera obtained the license for the worldwide exclusive rights to the technology develop... Read More